Vitamin D Supplementation Dose as The Prevention of Fragility Fracture In Chronic Kidney Disease Patient: A Systematic Review

Authors

  • Aldico J Sapardan RSUD Kabupaten Bekasi
  • Rashida S Djatnika RSUD Kabupaten Bekasi

DOI:

https://doi.org/10.59141/jsi.v6i02.118

Keywords:

Vitamin D, Supplementation, Prevention, Fragility fracture, Chronic kidney disease

Abstract

CKD affects more than 10% of the global population. It can cause osteoporosis and increase the risk of fractures, especially as CKD becomes more serious. In CKD, mineral and bone disorders (CKD-MBD) cause abnormalities in how the body processes vitamin D, calcium, phosphorus, or parathyroid hormone (PTH). It can also affect bone strength and cause calcium build-up in the soft tissues. Treatment usually starts with correcting the chemical abnormalities that occur in the body due to CKD-MBD before focusing on osteoporosis and fractures. A study review spanning 2010 to 2023 investigated optimal vitamin D supplementation doses in CKD patients, indicating varied outcomes influenced by factors like dosage, duration, and population characteristics. Doses ranged from 800 to 8,000 IU/day of cholecalciferol, with recommendations contingent on serum 25(OH)D levels.

Downloads

Download data is not yet available.

Downloads

Published

2024-05-20

How to Cite

Sapardan, A. J., & Djatnika, R. S. (2024). Vitamin D Supplementation Dose as The Prevention of Fragility Fracture In Chronic Kidney Disease Patient: A Systematic Review. Jurnal Sehat Indonesia (JUSINDO), 6(02), 681–685. https://doi.org/10.59141/jsi.v6i02.118